Skip to Content

Flector Approval History

  • FDA approved: Yes (First approved January 31st, 2007)
  • Brand name: Flector
  • Generic name: diclofenac epolamine
  • Dosage form: Topical Patch
  • Company: Institut Biochimique SA
  • Treatment for: Pain

Flector is a transdermal patch formulation of the nonsteroidal anti-inflammatory drug diclofenac, indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.

Development History and FDA Approval Process for Flector

DateArticle
Jan 31, 2007Approval Flector Approved - Institut Biochimique SA - Treatment for acute pain due to minor strains, sprains, and contusions.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide